Qilu Pharmaceutical Co., Ltd.
Records under this name other than the patents Qilu Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 3 of 3 · Back to Qilu Pharmaceutical Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,938,301 | Dihydropyrimido fused ring derivative as HBV inhibitor Lapsed on the fee record Ended Apr 10, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 10, 2026 | USPTO record |
| US 8,637,681 | Pyrrolyl substituted dihydroindol-2-one derivatives, preparation methods and uses thereof Lapsed on the fee record Ended Jan 28, 2018 · USPTO record | Lapsed on the fee record | Ended Jan 28, 2018 | USPTO record |
| US 6,875,890 | Method of producing N, N-dimethyl glycine hydrochloride Formerly held Lapsed on the fee record Ended Apr 5, 2017 · USPTO record | Lapsed on the fee record | Ended Apr 5, 2017 | USPTO record |